Premium Reports
KLAS Contact

Contact KLAS

info@klasresearch.com

801.226.5120

KLAS - Contact KLAS
 Download Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

Related Blogs

 End chart zoom
Bluesight Insights Bluesight Insights
* A page refresh may be necessary to see the updated image

Bluesight Insights
Emerging Technology Spotlight 2021

author - Jackson Tate
Author
Jackson Tate
author - Joshua Jensen
Author
Joshua Jensen
author - Sam Eaquinto
Author
Sam Eaquinto
 
May 28, 2021 | Read Time: 1  minute

Current Time Inside Cache Tag Helper: 9/17/2021 3:57:24 PM and Model.reportId = 1926

Kit Check has created Bluesight Insights to help maximize savings by streamlining medication purchasing and cost containment. The solution identifies unused wholesaler contracts that have reduced pricing for preferred drugs, highlights savings through additional drug programs (e.g., 340B, MedShorts, etc.), and gives proactive alerts to avoid over-invoicing. This KLAS Spotlight will examine the experiences of early adopters using Bluesight Insights.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 9/17/2021 3:57:24 PM and Model.reportId = 1926

Key Findings

  1. Bluesight Insights Customer Experience: An Initial Look
  2. Strengths and Challenges
  3. KLAS' Points to Ponder
  4. Bluesight Insights: Company Profile at a Glance
  5. Solution Technical Specifications (provided by Bluesight Insights)
author - Madison Fujimoto
Designer
Madison Fujimoto
author - Joshua Jensen
Project Manager
Joshua Jensen
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.